Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.5600
-0.0130 (-2.27%)
Aug 1, 2025, 4:00 PM - Market closed

Xtant Medical Holdings Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Xtant Medical Holdings.

Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Xtant Medical Holdings.

Recommendation Trends

RatingJan '24Feb '24Mar '24Apr '24May '24
Strong Buy22220
Buy00000
Hold00000
Sell00000
Strong Sell00000
Total22220

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Strong Buy
Maintains
$2$3
Strong BuyMaintains$2$3+435.71%May 16, 2024
BTIG
BTIG
Strong Buy
Initiates
$2
Strong BuyInitiates$2+257.14%Dec 5, 2023
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$1$1.2
Strong BuyMaintains$1$1.2+114.29%Jul 11, 2023
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$1
Strong BuyInitiates$1+78.57%Apr 26, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
132.14M
from 117.27M
Increased by 12.68%
Revenue Next Year
139.28M
from 132.14M
Increased by 5.40%
EPS This Year
-0.04
from -0.12
EPS Next Year
-0.02
from -0.04
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
53.34M55.26M57.97M91.30M117.27M132.14M139.28M151.16M
Revenue Growth
-17.54%3.61%4.90%57.50%28.44%12.68%5.40%8.53%
EPS
-0.25-0.06-0.090.01-0.12-0.04-0.02-
EPS Growth
--------
Forward PE
--------
No. Analysts
-----443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High136.2M143.6M155.6M
Avg132.1M139.3M151.2M
Low126.8M133.6M145.2M

Revenue Growth

Revenue Growth202520262027
High
16.1%
8.7%
11.7%
Avg
12.7%
5.4%
8.5%
Low
8.1%
1.1%
4.3%

EPS Forecast

EPS20252026
High-0.02-
Avg-0.04-0.02
Low-0.05-0.03

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.